The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $23,340 purchase order to Bio-Rad Laboratories, Inc.'s Diagnostics Division for maintenance services. As the prime contractor, Bio-Rad Laboratories will perform the maintenance work itself at its facility in Hercules, California under a firm fixed price contract that runs from January 2024 through January 2025. No subcontractors or set-aside designations were identified. The award...
Bio-Rad Laboratories, Inc. Life Science Group Division has been awarded a $19,536 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide maintenance services for equipment located in Hercules, California under a maintenance agreement expiring March 31, 2024. This award is not designated as a set-aside. Bio-Rad Laboratories holds a five-year, one billion dollar blanket purchase agreement with the Department...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $10,704 firm fixed price blanket purchase agreement call contract to Bio-Rad Laboratories, Inc. Life Science Group Division for maintenance services on a government-owned CFX 384 well real time quantitative polymerase chain reaction system and CFX 96 well optical module located in Bethesda, Maryland. As the prime contractor, Bio-Rad will provide maintenance and support for the...
This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The $18,625.40 contract is for a maintenance agreement, with a period of performance ending on April 5, 2025. Bio-Rad Laboratories, Inc. is an experienced federal contractor that has been awarded numerous contracts and...
This federal contract award is for a MAINTENANCE AGREEMENT between the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), and Bio-Rad Laboratories, Inc. The contract has a ceiling value of $10,783.00 and a completion date of December 31, 2025. It was awarded on January 1, 2025 as a Firm Fixed Price Purchase Order. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is the prime contractor and is a global...
This federal contract award is to Bio-Rad Laboratories, Inc.'s Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract, valued at $1,133.06, was awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call, with a fixed price redetermination pricing type. The contract does not have a...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $25,000 purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a CHEMIDOC imaging system. The firm fixed price contract has a period of performance from December 31, 2023 through December 31, 2023 for delivery of the requested product to Bio-Rad's facility in Hercules, California. No set aside designation or subcontractors were identified. The CHEMIDOC...
The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $14,363.29 firm-fixed-price purchase order contract to Bio-Rad Laboratories, Inc. for a service contract to provide a Biorad Automated Droplet PCR System. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics products. The company has established relationships with multiple...
This federal contract award is for a maintenance agreement on various laboratory equipment, valued at $30,087.45, awarded by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is the parent company of the prime contractor and has established significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with various federal agencies,...
This federal contract award, valued at $24,995.00, was issued by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type. It does not have a set-aside designation. Bio-Rad Laboratories, Inc. is a leading global manufacturer and supplier of specialized equipment, reagents, and consumables for life...